Karuna Therapeutics Inc (NASDAQ:KRTX)
| 166.02 Delayed Data As of Sep 22 |  -2.13 / -1.27%Today’s Change | 159.73 Today|||52-Week Range 245.00 | -15.51% Year-to-Date |
Latest KRTX News | Press Releases
No recent news for Karuna Therapeutics Inc.
Today’s Trading
| Previous close | 168.15 |
| Today’s open | 167.66 |
| Day’s range | 166.02 - 167.90 |
| Volume | 7,271 |
| Average volume (3 months) | 332,305 |
| Market cap | $6.3B |
Data as of 3:59pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | -77.03% |
| Earnings growth (this year) | -33.78% |
| Earnings growth (next 5 years) | -86.37% |
| Revenue growth (last year) | -71.22% |
| P/E ratio | NM |
| Price/Sales | 584.29 |
| Price/Book | 5.14 |
Competitors
Data as of 3:59pm ET, 09/22/2023
Financials
| Next reporting date | November 2, 2023 |
| EPS forecast (this quarter) | -$2.92 |
| Annual revenue (last year) | $10.6M |
| Annual profit (last year) | -$276.3M |
| Net profit margin | -2,597.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
